Table 1 Clinical characteristics of the cases
From: A case series of post COVID-19 mucormycosis—a neurological prospective
Gender | Age | Medical history | COVID-19 infection date | Time of presentation | Cranial nerves involved | Mucormycosis type (clinical and radiological basis) | Culture/pathology | Fate | |
|---|---|---|---|---|---|---|---|---|---|
Patient 1 | F | 59 | DM | January 2021 | 21 days post a negative PCR 14 days since sinusitis | II, III, IV, V2, VI, VII | Rhino-orbito-cerebral and cutaneous | Not obtained (died pre-operation) | Died |
Patient 2 | M | 80 | DM, HTN, operated cancer colon, chronic renal impairment | April 2021 | 30 days post a negative PCR Incidental presentation of palatal blackish ulcer | II | Rhino-orbito-cerebral | Not obtained (discharged against medical will before procedure) | Alive |
Patient 3 | M | 73 | DM, HTN, ISHD and cardiac stenting | April 2021 | 14 days post a negative PCR 10 days since sinusitis | III, IV, VI | Rhino-orbito-cerebral | Positive pathology going with mucormycosis | Alive with a lost eye |
Patient 4 | M | 59 | DM, HTN | March 2021 | 10 days post a negative PCR 6 days since sinusitis | III, IV, VI | Rhino-orbito-cerebral | Positive culture (zygomycetes) | Alive |